Evidence for use of fibrates in diabetic dyslipidemia: are we looking hard enough?
Curr Opin Lipidol
.
2011 Feb;22(1):76-7.
doi: 10.1097/MOL.0b013e328342b0e9.
Authors
Srinivasa P Munigoti
,
Alan Rees
PMID:
21233625
DOI:
10.1097/MOL.0b013e328342b0e9
No abstract available
Publication types
Editorial
Review
MeSH terms
Diabetes Complications / drug therapy
Dyslipidemias / drug therapy*
Dyslipidemias / etiology*
Fibric Acids / therapeutic use*
Humans
PPAR alpha / agonists
Substances
Fibric Acids
PPAR alpha